Real-world outcomes of DAA treatment and retreatment in UK-based patients infected with HCV genotypes/subtypes endemic in Africa E Aranday-Cortes, CP McClure, C Davis, WL Irving, K Adeboyejo, L Tong J Infect Dis 226, 995-1004, 2021 | 6 | 2021 |
Real-world outcomes of direct-acting antiviral treatment and Retreatment in United Kingdom–based patients infected with hepatitis C virus Genotypes/subtypes Endemic in Africa E Aranday-Cortes, CP McClure, C Davis, WL Irving, K Adeboyejo, L Tong, ... The Journal of infectious diseases 226 (6), 995-1004, 2022 | 5 | 2022 |
Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil K Adeboyejo, VR Grosche, DP José, GM Ferreira, JF Shimizu, BJ King, ... Access Microbiology 4 (3), 000326, 2022 | 4 | 2022 |
In vitro Antimicrobial Activity of Clerodendron Polycephalum Against Clinical Bacterial Isolates AM Deji-Agboola, FA Olajubu, KA Adeboyejo, OO Onakalu, HI Effedua, ... Nigerian Medical Practitioner 55 (3), 2009 | 4 | 2009 |
Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination K Adeboyejo, BJ King, T Tsoleridis, AW Tarr, J McLauchlan, WL Irving, ... Journal of Medical Virology 95 (1), e28178, 2023 | | 2023 |
Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil KA Adeboyejo University of Nottingham, 2020 | | 2020 |